© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Moolec Science S.A. (MLECW) stock declined over -14.74%, trading at $0.01 on NASDAQ, down from the previous close of $0.02. The stock opened at $0.01, fluctuating between $0.01 and $0.01 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 51 |
| Sep 08, 2026 | 0.01 | 0.01 | 0.01 | 0.01 | 8.78K |
| Sep 04, 2026 | 0.01 | 0.02 | 0.01 | 0.02 | 5.5K |
| Sep 03, 2026 | 0.01 | 0.02 | 0.01 | 0.01 | 3 |
| Sep 02, 2026 | 0.01 | 0.02 | 0.01 | 0.02 | 6.77K |
| Sep 01, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 981 |
| Aug 31, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 151 |
| Aug 28, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 431 |
| Aug 27, 2026 | 0.01 | 0.02 | 0.01 | 0.02 | 403 |
| Aug 25, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 459 |
| Aug 24, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 284 |
| Aug 21, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 242 |
| Aug 19, 2026 | 0.02 | 0.02 | 0.02 | 0.02 | 8.22K |
| Aug 18, 2026 | 0.02 | 0.02 | 0.01 | 0.02 | 518 |
| Aug 17, 2026 | 0.02 | 0.02 | 0.01 | 0.01 | 10.6K |
| Aug 14, 2026 | 0.01 | 0.02 | 0.01 | 0.02 | 7.27K |
| Aug 13, 2026 | 0.01 | 0.02 | 0.01 | 0.02 | 30.2K |
| Aug 12, 2026 | 0.01 | 0.02 | 0.01 | 0.02 | 15.74K |
| Aug 10, 2026 | 0.02 | 0.02 | 0.01 | 0.02 | 7.23K |
| Aug 07, 2026 | 0.02 | 0.02 | 0.01 | 0.01 | 7 |
Moolec Science S.A. operates as a science-driven ingredient company focused on generating animal proteins inside plants through a groundbreaking method called Molecular Farming. This innovative approach is considered a disruptive force in the alternative protein sector. The firm's existing and future products strategically utilize the strong agricultural performance of key crops, such as soybeans and peas. Established in 2008, Moolec Science S.A. is headquartered in Luxembourg and conducts business across the United States, Europe, and South America.
| Employees | 52 |
| Beta | 0.09 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Biotechnology |